术前肌肉脂肪变性联合白蛋白–球蛋白评分对根治性术后胆管癌患者预后的预测价值
Prognostic Value of Preoperative Myosteatosis Combined with Albumin-Globulin Score in Patients with Cholangiocarcinoma after Radical Surgery
DOI: 10.12677/ACM.2024.143789, PDF,    科研立项经费支持
作者: 刘 艳*, 荆 雪#:青岛大学附属医院消化内科,山东 青岛
关键词: 胆管细胞癌肌肉脂肪变性白蛋白–球蛋白评分根治性手术预后Cholangiocarcinoma Myosteatosis Albumin-Globulin Score Radical Surgery Prognosis
摘要: 背景与目的:肌肉脂肪变性与多种恶性肿瘤的不良预后相关。术前白蛋白与球蛋白联合得到的白蛋白–球蛋白评分(AGS),可预测食管癌、肺癌等恶性肿瘤的预后。本研究旨在探索术前肌肉脂肪变性联合白蛋白–球蛋白评分对胆管癌根治性切除患者的预测价值。方法:回顾性纳入2017年1月至2022年3月在青岛大学附属医院接受根治性切除手术的155例胆管癌患者。收集患者的血清学及影像学资料,采用Slice-O-Matic软件进行身体成分分析,Kaplan-Meier方法进行生存分析,Cox回归分析与患者总生存期和无复发生存期相关的风险因素。结果:本研究共纳入82例肌肉脂肪变性,73例非肌肉脂肪变性患者。Kaplan-Meier曲线显示肌肉脂肪变性与总生存期和无复发生存期相关(P = 0.022和P = 0.017),高AGS组患者的总生存期和无复发生存期明显短于低AGS组患者(P = 0.015和P = 0.009)。同时存在高AGS和肌肉脂肪变性的患者生存期和无复发生存期最短(P = 0.005和P = 0.002)。结论:本研究表明,对于接受根治性切除手术的胆管细胞癌患者,术前存在肌肉脂肪变性且高白蛋白–球蛋白评分时,预后最差。以上提示临床医生尽早开展营养支持以及干预肌肉衰减的治疗。
Abstract: Background and Purpose: Myosteatosis is associated with poor prognosis of various malignancies. The albumin-globulin score (AGS) obtained by the combination of albumin and globulin before op-eration can predict the prognosis of malignant tumors such as esophageal cancer and lung cancer. The objective of this study was to explore the predictive value of preoperative myosteatosis com-bined with albumin-globulin score in patients undergoing radical cholangiocarcinoma resection. Methods: A total of 155 patients with cholangiocarcinoma who underwent radical resection in the Affiliated Hospital of Qingdao University from January 2017 to March 2022 were retrospectively in-cluded. Serological and imaging data of the patients were collected. Slice-O-Matic software was used for body composition analysis, Kaplan-Meier method for survival analysis, and Cox regression anal-ysis was performed to analyze the risk factors associated with overall survival and relapse-free sur-vival of the patients. Results: A total of 82 patients with myosteatosis and 73 patients with non-myosteatosis were included in this study. Kaplan-Meier curve showed that myosteatosis was correlated with overall survival and relapse-free survival (P = 0.022 and P = 0.017), and the overall survival and relapse-free survival of patients with high AGS were significantly shorter than those in patients with low AGS (P = 0.015 and P = 0.009). Patients with both high AGS and myosteatosis had the shortest survival and relapse-free survival (P = 0.005 and P = 0.002). Conclusions: This study showed that patients with cholangiocarcinoma who underwent radical resection had the worst prognosis when myosteatosis and high albumin-globulin score were present before surgery. These results suggest that clinicians should start nutritional support and intervention therapy for muscle decay as early as possible.
文章引用:刘艳, 荆雪. 术前肌肉脂肪变性联合白蛋白–球蛋白评分对根治性术后胆管癌患者预后的预测价值[J]. 临床医学进展, 2024, 14(3): 900-908. https://doi.org/10.12677/ACM.2024.143789

参考文献

[1] Cankurtaran, R.E., Güneş, Y.C., Dirican, E., et al. (2023) Sarcopenia and Myosteatosis Assessed by Magnetic Reso-nance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease. Turkish Journal of Gastroenter-ology, 34, 839-849. [Google Scholar] [CrossRef] [PubMed]
[2] Petric, M., Jordan, T., Karteek, P., et al. (2023) Radiological Assessment of Skeletal Muscle Index and Myosteatosis and Their Impact Postoperative Outcomes after Liver Transplantation. Radiology and Oncology, 57, 168-177. [Google Scholar] [CrossRef] [PubMed]
[3] Feng, S., Mu, H., Hou, R., et al. (2022) Prognostic Value of Myoste-atosis in Patients with Lung Cancer: A Systematic Review and Meta-Analysis. International Journal of Clinical Oncolo-gy, 27, 1127-1138. [Google Scholar] [CrossRef] [PubMed]
[4] Kim, D.W., Ahn, H., Kim, K.W., et al. (2022) Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Korean Journal of Radi-ology, 23, 1055-1066. [Google Scholar] [CrossRef] [PubMed]
[5] Fang, T., Gong, Y. and Wang, Y. (2023) Prognostic Values of Myoste-atosis for Overall Survival in Patients with Gastric Cancers: A Meta-Analysis with Trial Sequential Analysis. Nutrition, 105, Article ID: 111866. [Google Scholar] [CrossRef] [PubMed]
[6] Engelmann, S.U., Pickl, C., Haas, M., et al. (2023) Body Composi-tion of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myoste-atosis Are Independent Risk Factors for Mortality. Cancers (Basel), 15, Article No. 1778. [Google Scholar] [CrossRef] [PubMed]
[7] Ryan, A.M., Power, D.G., Daly, L., et al. (2016) Cancer-Associated Malnutrition, Cachexia and Sarcopenia: The Skeleton in the Hospital Closet 40 Years Later. Proceedings of the Nutrition Society, 75, 199-211. [Google Scholar] [CrossRef
[8] Xie, D., Lu, P.L., Xu, W., et al. (2023) Correlation of Serum Albumin Level on Postoperative Day 2 with Hospital Length of Stay in Patients Undergoing Emergency Surgery for Perforated Peptic Ulcer. World Journal of Gastrointestinal Surgery, 15, 1434-1441. [Google Scholar] [CrossRef] [PubMed]
[9] Cai, Y., Zhao, Y., Dai, Q., et al. (2021) Prognostic Value of the Al-bumin-Globulin Ratio and Albumin-Globulin Score in Patients with Multiple Myeloma. Journal of International Medical Research, 49. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, Y., Wang, N., Xu, L., et al. (2023) Albumin-Globulin Score Combined with Skeletal Muscle Index as a Novel Prognostic Marker for Hepatocellular Carcinoma Patients Un-dergoing Liver Transplantation. Journal of Clinical Medicine, 12, Article No. 2237. [Google Scholar] [CrossRef] [PubMed]
[11] Li, X., Qin, S., Sun, X., et al. (2018) Prognostic Significance of Albu-min-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer. Annals of Surgical Oncology, 25, 3647-3659. [Google Scholar] [CrossRef] [PubMed]
[12] Mitsiopoulos, N., Baumgartner, R.N., Heymsfield, S.B., et al. (1998) Cadaver Validation of Skeletal Muscle Measurement by Magnetic Resonance Imaging and Computerized Tomog-raphy. Journal of Applied Physiology (1985), 85, 115-122. [Google Scholar] [CrossRef] [PubMed]
[13] Ebadi, M., Tsien, C., Bhanji, R.A., et al. (2022) Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mecha-nisms and Potential Interventions. Cells, 11, Article No. 1216. [Google Scholar] [CrossRef] [PubMed]
[14] Zeng, X., Shi, Z.W., Yu, J.J., et al. (2023) Skeletal Muscle Alterations Indicate Poor Prognosis in Cirrhotic Patients: A Multicenter Cohort Study in China. Hepatology International. [Google Scholar] [CrossRef] [PubMed]
[15] Geladari, E., Alexopoulos, T., Kontogianni, M.D., et al. (2023) The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis. Journal of Clinical Medicine, 12, Article No. 3332. [Google Scholar] [CrossRef] [PubMed]
[16] Kiefer, L.S., Fabian, J., Rospleszcz, S., et al. (2018) Assessment of the Degree of Abdominal Myosteatosis by Magnetic Resonance Imaging in Subjects with Diabetes, Prediabetes and Healthy Controls from the General Population. European Journal of Radiology, 105, 261-268. [Google Scholar] [CrossRef] [PubMed]
[17] Ahn, H., Kim, D.W., Ko, Y., et al. (2021) Updated Systematic Review and Meta-Analysis on Diagnostic Issues and the Prognostic Impact of Myosteatosis: A New Paradigm Beyond Sarcopenia. Ageing Research Reviews, 70, Article ID: 101398. [Google Scholar] [CrossRef] [PubMed]
[18] Scopel Poltronieri, T., De Paula, N.S. and Chaves, G.V. (2022) Skeletal Muscle Radiodensity and Cancer Outcomes: A Scoping Review of the Literature. Nutrition in Clinical Practice, 37, 1117-1141. [Google Scholar] [CrossRef] [PubMed]
[19] Aleixo, G.F.P., Shachar, S.S., Nyrop, K.A., et al. (2020) Myosteatosis and Prognosis in Cancer: Systematic Review and Meta-Analysis. Critical Reviews in Oncolo-gy/Hematology, 145, Article ID: 102839. [Google Scholar] [CrossRef] [PubMed]
[20] Cespiati, A., Meroni, M., Lombardi, R., et al. (2022) Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiolo-gies and Possible Therapeutic Strategies. Biomedicines, 10, Article No. 182. [Google Scholar] [CrossRef] [PubMed]
[21] Ding, L., De Munck, T.J.I., Oligschlaeger, Y., et al. (2021) Myosteatosis in NAFLD Patients Correlates with Plasma Cathepsin D. Biomolecular Concepts, 12, 27-35. [Google Scholar] [CrossRef] [PubMed]
[22] Hamrick, M.W., Mcgee-Lawrence, M.E. and Frechette, D.M. (2016) Fatty Infiltration of Skeletal Muscle: Mechanisms and Comparisons with Bone Marrow Adiposity. Frontiers in Endo-crinology (Lausanne), 7, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[23] Lutz, C.T. and Quinn, L.S. (2012) Sarcopenia, Obesity, and Natural Killer Cell Immune Senescence in Aging: Altered Cytokine Levels as a Common Mechanism. Aging (Albany NY), 4, 535-546. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, W.Z., Shen, Z.L., Zhang, F.M., et al. (2022) Prognos-tic Value of Myosteatosis and Sarcopenia for Elderly Patients with Colorectal Cancer: A Large-Scale Double-Center Study. Surgery, 172, 1185-1193. [Google Scholar] [CrossRef] [PubMed]
[25] Lurje, I., Uluk, D., Pavicevic, S., et al. (2023) Body Composition Is Associated with Disease Aetiology and Prognosis in Patients Undergoing Resection of Intrahepatic Cholangiocarci-noma. Cancer Medicine, 12, 17569-17580. [Google Scholar] [CrossRef] [PubMed]
[26] Correa-De-Araujo, R., Addison, O., Miljkovic, I., et al. (2020) Myosteato-sis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Frontiers in Physiology, 11, Article No. 963. [Google Scholar] [CrossRef] [PubMed]
[27] Maslennikov, R., Alieva, A., Poluektova, E., et al. (2023) Sarcopenia in Cirrhosis: Prospects for Therapy Targeted to Gut Microbiota. World Journal of Gastroenterology, 29, 4236-4251. [Google Scholar] [CrossRef] [PubMed]
[28] Stretch, C., Aubin, J.M., Mickiewicz, B., et al. (2018) Sarcopenia and Myosteatosis Are Accompanied by Distinct Biological Pro-files in Patients with Pancreatic and Periampullary Adenocarcinomas. PLOS ONE, 13, E0196235. [Google Scholar] [CrossRef] [PubMed]
[29] Salavatizadeh, M., Soltanieh, S., Radkhah, N., et al. (2023) The Association between Skeletal Muscle Mass Index (SMI) and Survival after Gastrectomy: A Systematic Review and Me-ta-Analysis of Cohort Studies. European Journal of Surgical Oncology, 49, Article ID: 106980. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, H., Qi, G., Wang, K., et al. (2023) Oxidative Stress: Roles in Skeletal Muscle Atrophy. Biochemical Pharmacology, 214, Article ID: 115664. [Google Scholar] [CrossRef] [PubMed]
[31] Jang, J.Y., Kim, D. and Kim, N.D. (2023) Pathogenesis, Interven-tion, and Current Status of Drug Development for Sarcopenia: A Review. Biomedicines, 11, Article No. 1635. [Google Scholar] [CrossRef] [PubMed]
[32] Okugawa, Y., Kitajima, T., Yamamoto, A., et al. (2022) Clini-cal Relevance of Myopenia and Myosteatosis in Colorectal Cancer. Journal of Clinical Medicine, 11, Article No. 2617. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, Z., Song, C., Yao, Z., et al. (2022) Associations between Albu-min, Globulin, Albumin to Globulin Ratio and Muscle Mass in Adults: Results from the National Health and Nutrition Examination Survey 2011-2014. BMC Geriatrics, 22, Article No. 383. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, F., Sun, P., Wang, Z.Q., et al. (2016) Low Preoperative Albumin-Globulin Score Predicts Favorable Survival in Esophageal Squamous Cell Carcinoma. Oncotarget, 7, 30550-30560. [Google Scholar] [CrossRef] [PubMed]
[35] Chen, L., Yu, G., Zhao, W., et al. (2023) A Possible Combined Appraisal Pattern: Predicting the Prognosis of Patients after Esophagectomy. World Journal of Surgical On-cology, 21, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[36] Li, H., Dai, J., Lan, T., et al. (2021) Combination of Albu-min-Globulin Score and Skeletal Muscle Index Predicts Long-Term Outcomes of Intrahepatic Cholangiocarcinoma Pa-tients after Curative Resection. Clinical Nutrition, 40, 3891-3900. [Google Scholar] [CrossRef] [PubMed]